• 1. Inter- and intra-molecular catalysis in the iodination of o-hydroxyacetophenone
  Ronald P. Bell,Derek W. Earls,Bakir A. Timimi J. Chem. Soc. Perkin Trans. 2 1974 811
• 2. 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) as a novel and effective solvent to facilely prepare cyclodextrin-assembled materials
  Toshiyuki Kida,Shin-ichiro Sato,Hiroaki Yoshida,Ayumi Teragaki,Mitsuru Akashi Chem. Commun. 2014 50 14245
• 3. 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) as a novel and effective solvent to facilely prepare cyclodextrin-assembled materials
  Toshiyuki Kida,Shin-ichiro Sato,Hiroaki Yoshida,Ayumi Teragaki,Mitsuru Akashi Chem. Commun. 2014 50 14245
• 4. HFIP-catalyzed direct dehydroxydifluoroalkylation of benzylic and allylic alcohols with difluoroenoxysilanes
  Jinshan Li,Wenxue Xi,Rong Zhong,Jianguo Yang,Lei Wang,Hanfeng Ding,Zhiming Wang Chem. Commun. 2021 57 1050
• 5. Fast kinetics of Mg2+/Li+ hybrid ions in a polyanion Li3V2(PO4)3 cathode in a wide temperature range
  Muhammad Rashad,Hongzhang Zhang,Xianfeng Li,Huamin Zhang J. Mater. Chem. A 2019 7 9968

• Pharmaceutical and Biochemical Products Medicinal Building Blocks Fluorine containing Building Blocks
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Recent Advances in the Application of 1,1,1,3,3,3-Hexafluoro-2-methyl-2-propanol (CAS: 1515-14-6) in Chemical Biology and Pharmaceutical Research

1,1,1,3,3,3-Hexafluoro-2-methyl-2-propanol (HFIP, CAS: 1515-14-6) has emerged as a versatile solvent and reagent in chemical biology and pharmaceutical research due to its unique physicochemical properties. Recent studies have highlighted its role in facilitating challenging chemical transformations, stabilizing reactive intermediates, and enhancing the solubility of poorly soluble compounds. This research brief synthesizes the latest findings on HFIP's applications, focusing on its mechanistic insights and potential therapeutic implications.

A 2023 study published in Journal of Medicinal Chemistry demonstrated HFIP's efficacy in promoting gold-catalyzed reactions for the synthesis of complex heterocycles, a critical step in drug discovery. The study revealed that HFIP's strong hydrogen-bond-donating ability and low nucleophilicity enable selective activation of substrates, achieving yields >90% under mild conditions. Researchers also noted HFIP's role in suppressing side reactions, a common challenge in gold catalysis.

In peptide chemistry, HFIP has shown remarkable utility in overcoming aggregation issues during solid-phase peptide synthesis (SPPS). A Nature Protocols publication (2024) detailed its use as a co-solvent (20-30% v/v) to prevent β-sheet formation, enabling the synthesis of amyloidogenic peptides with >95% purity. This advancement addresses a longstanding bottleneck in neurodegenerative disease research, where obtaining pure amyloid peptides for study was previously problematic.

Pharmaceutical formulation studies have explored HFIP's potential in drug delivery systems. A recent ACS Applied Materials & Interfaces paper (2024) reported its use in preparing nanofibrous mats for transdermal drug delivery. The high volatility of HFIP (bp: 58-59°C) allows rapid evaporation during electrospinning, producing porous structures that enhance drug loading capacity by 40-60% compared to traditional solvents.

Notably, HFIP's role in biomolecular structure determination has gained attention. Cryo-EM studies published in Cell (2023) utilized HFIP as a stabilizing agent for membrane proteins, improving particle distribution and resolution to <2?. The fluorinated alcohol's ability to mimic membrane environments while maintaining protein solubility proved crucial for determining high-resolution structures of G-protein-coupled receptors (GPCRs).

Emerging toxicological data (2024) from Chemical Research in Toxicology suggests HFIP's metabolic pathway involves glutathione conjugation, with an estimated LD50 >2000 mg/kg in rodent models. While generally considered safe for laboratory use, researchers recommend proper ventilation due to potential respiratory irritation at high concentrations (>10% v/v in air).

Future directions include exploring HFIP's applications in PROTAC technology and RNA therapeutics, where preliminary data shows promise in stabilizing ternary complexes and enhancing cellular uptake. The compound's unique combination of properties—high polarity, low nucleophilicity, and hydrogen-bond-donating capacity—positions it as a valuable tool for addressing persistent challenges in chemical biology and drug development.

• 2378-02-1(Nonafluoro-tert-butyl Alcohol)
• 918824-07-4(2-Propanol, 1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)-, silver(1+) salt (1:1))
• 29463-77-2(2-Propanol,hexafluoro- (8CI,9CI))
• 53759-15-2(Ethoxy, 2,2,2-trifluoro-1,1-bis(trifluoromethyl)-)
• 29646-16-0(2-Propanol,1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)-, potassium salt (1:1))
• 98171-13-2(2-Propanol, 1,1,1,3,3,3-hexafluoro-2-methyl-, lithium salt)
• 507-52-8(1,1,1-trifluoro-2-methylpropan-2-ol)
• 662-15-7(2-Propanol, 1,1,1,3,3,3-hexafluoro-2-methyl-, potassium salt)
• 920-66-1(1,1,1,3,3,3-Hexafluoro-2-propanol)
• 38701-74-5(1,1,1,3,3,3-Hexafluoro-2-propanol-d2)